• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.85% Nasdaq Up 0.55%

    ImmunoCellular Therapeutics, Ltd. (IMUC)

    -NYSE MKT
    0.22 Up 0.00(1.97%) 11:48AM EDT - Nasdaq Real Time Price
    Prev Close:0.21
    Open:0.22
    Bid:0.22 x 2300
    Ask:0.22 x 1900
    1y Target Est:2.50
    Beta:0.933489
    Earnings Date:Aug 4 - Aug 8 (Est.)
    Day's Range:0.20 - 0.23
    52wk Range:0.20 - 0.64
    Volume:477,733
    Avg Vol (3m):296,003
    Market Cap:20.23M
    P/E (ttm):N/A
    EPS (ttm):-0.19
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for IMUC

    Comparison

    Symbol% ChgMkt Cap
    IMUCUp 1.97%20.23M
    STMLDown 0.15%122.83M
    AGENUp 0.79%331.89M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.27
    Quarterly EPS Est (Jun-16) :-0.07
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company, develops immune-based therapies for the treatment of brain and ovarian cancers. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback